The ovarian cancer market has transformed in recent years, driven by the expanding use of PARP inhibitors, antiangiogenic ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival compared with neoadjuvant chemo and interval cytoreductive surgery.

Ditch these lifestyle habits that could be raising your ovarian cancer risk.(Image by Pexels) The average overall 5-year survival rates are approximately 48.6 per cent.

Staying at a healthy weight, being physically active throughout life, following a healthy eating pattern, and avoiding or limiting alcohol may greatly reduce your risk of developing or dying from ...

While some cancers have shown improved outcomes—ovarian cancer survival rose from 36% in 1975 to 51% in 2019—others, like endometrial cancer, have seen declining survival and rising mortality ...

Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s ...

In other recent news, Imunon Inc. announced significant findings from its Phase 2 trial of IMNN-001 for advanced ovarian cancer, showcasing a median 13-month increase in overall survival for ...

US-based biotechnology company Imunon has reported positive results from its Phase II OVATION 2 trial of IMNN-001 for ovarian cancer. The results showed that when given to women recently diagnosed ...

Ovarian cysts usually aren't a cause for concern, but here's what should tip you off to see a doctor. Watch Party Newsletter DIY projects to try Avoid inflammation 🥣 Is Pilates for you?

CHICAGO — The addition of relacorilant to nab-paclitaxel significantly extended survival for women with platinum-resistant ovarian cancer, according to results of the randomized phase 3 ROSELLA ...